NEOGAP Therapeutics AB logo

NEOGAP Therapeutics AB

Science for cure.

28 employees · est. 2016 · Stockholm, Sweden

VS
OmniSeq logo

OmniSeq

The Right Drug or Trial for Every Patient.

28 employees · est. 2015 · Buffalo, United States

OmniSeq is the older company (2016 vs 2015).

Side-by-Side Comparison

NEOGAP Therapeutics AB OmniSeq
Founded
2016 2015 older
Headquarters
Stockholm, Sweden Buffalo, United States
Employees
28 28
Industry
Biotechnology, Health Care, Pharmaceutical Biopharma, Biotechnology, Health Care
Funding Stage
Grant Series Unknown
Total Funding
$147.66M Not tracked yet
Funding Rounds
5 Not tracked yet
Services
Not tracked yet Not tracked yet
Target Customers
Not tracked yet Not tracked yet
Taxonomy
Biopharmaceutical, Immunotherapy, Cancer Treatment, Clinical-stage Company, Cancer Immunotherapy, Immuno-oncology, Tumor-specific Responses, Personalized Cell Treatment, Clinical Stage Biopharmaceutical, Cancer Research, Precision Medicine, Innovative Therapy, Karolinska Institute, Stockholm, Sweden, Therapeutic Immune Design Not tracked yet
Website
neogap.se omniseq.com
NEOGAP Therapeutics AB logo

About NEOGAP Therapeutics AB

NEOGAP Therapeutics AB is a privately held clinical stage biopharmaceutical company with the main focus on immuno-oncology. The company was founded in 2016 by Dr. Hans Grönlund. We are located at Therapeutic Immune Design, Centre for Molecular Medicine at Karolinska Institute, Stockholm, Sweden. Ou...

OmniSeq logo

About OmniSeq

OmniSeq, an innovation of Roswell Park Cancer Institute, is a molecular diagnostic laboratory based in Buffalo, New York. OmniSeq endeavors to find the right drug or the right trial for every patient by improving access to better cancer treatment options through molecular profiling. In addition to...

We will tell you when either one moves

BounceWatch watches NEOGAP Therapeutics AB and OmniSeq for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at NEOGAP Therapeutics AB and OmniSeq — by email.

Frequently Asked Questions

NEOGAP Therapeutics AB — Science for cure. . OmniSeq — The Right Drug or Trial for Every Patient.. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
NEOGAP Therapeutics AB has raised $147.66M while OmniSeq has raised undisclosed funding.
NEOGAP Therapeutics AB and OmniSeq operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare NEOGAP Therapeutics AB with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at NEOGAP Therapeutics AB on 11 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes